If any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...

Key Points - Non-GAAP earnings per share were $0.74 for the fiscal second quarter ended June 30, 2025, beating estimates by $0.03 (non-GAAP). Revenue reached $1,140.4 million for the fiscal second ...

Key Points Earnings per share (Non-GAAP) were $0.94 in Q2 2025 beating the analyst estimate by 9.3% (non-GAAP) and the company exceeded its non-GAAP EPS outlook by $0.08. Net sales (GAAP) reached ...

Praxis Precision Medicine PRAX -4.09% Get Free Report will release its quarterly earnings report on Monday, 2025-08-04. Here's a brief overview for investors ahead of the announcement. Analysts ...

Management reaffirmed 2025 operating earnings per share guidance of $3.28 to $3.52, with a midpoint of $3.40. Ridge stated, "I'm highly confident in our ability to deliver on our financial plan, ...

Analysts are estimating that Castle Biosciences will report an earnings per share (EPS) of $-0.50. Investors in Castle Biosciences are eagerly awaiting the company's announcement, hoping for news of ...

Looking at specific segments, Amazon says North America sales increased 11% year-over-year to $100.1 billion; international ...

Schneider National's Q2 2025 earnings call reveals a focus on margin restoration, disciplined pricing, and growth via M&A.

CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation ...

Pfizer will report its fiscal second-quarter earnings on Aug. 5. Although we won't know if it'll continue its beats streak ...

The chip designer's results and guidance were not good enough to support its highly valued stock, but its attractive business ...

Qualcomm was one of the major tech companies to report on its latest quarterly earnings, and Q3 FY25 was a squeaker, but ...